5-methoxypsoralen has been researched along with Osteoarthritis in 1 studies
5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.
Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y | 1 |
| Zisan, Z | 1 |
| Lu, Z | 1 |
| Zheng, L | 1 |
| Zhao, J | 1 |
1 other study available for 5-methoxypsoralen and Osteoarthritis
| Article | Year |
|---|---|
Bergapten alleviates osteoarthritis by regulating the ANP32A/ATM signaling pathway.
Topics: 5-Methoxypsoralen; Animals; Anti-Inflammatory Agents; Ataxia Telangiectasia Mutated Proteins; Cell P | 2019 |